The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.
Journal of psychopharmacology (Oxford, England) June 25, 2026 Pavan S Brar, Rebecca B Price, Stephen Ross et al.
In the past decade, interest in studying psychedelic compounds as potential therapeutic agents has resurged. These studies carefully exclude individuals at risk for developing psychotic symptoms in response to psychedelic use. Given the potential for psychedelics to be established as treatments in psychiatry, it is important to more robustly understand their link with psychosis and...